SCHEMBL6651607

SCHEMBL6651607

CCOC(=O)C1=C(O)CC(C)c2ccc(Cl)cc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.47
LMNA P02545 3/20 0.44
KDM4E B2RXH2 3/20 0.42
MAPT P10636 3/20 0.42
ALOX12 P18054 2/20 0.42
ALDH1A1 P00352 1/20 0.42
TNF P01375 1/20 0.42
HSP90AA1 P07900 1/20 0.42
HPGD P15428 1/20 0.42
CCR6 P51684 1/20 0.42
RUNX1 Q01196 1/20 0.42
CBFB Q13951 1/20 0.42
HKDC1 Q2TB90 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
NOD2 Q9HC29 1/20 0.42
GPR35 Q9HC97 1/20 0.42
NOD1 Q9Y239 1/20 0.42
GAA P10253 1/20 0.40
SPR P35270 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3303821 0.68 CA1 (0.70) MAPK1LMNAKDM4EMAPTALOX12
SCHEMBL235046 0.67 TSHR (0.60) MAPK1KDM4EMAPTALDH1A1KMT2A
SCHEMBL21474571 0.67 MAPK1 (0.42) MAPK1LMNAALOX12ALDH1A1HPGD
SCHEMBL11225504 0.66 CYP4F2 (0.67) MAPK1KDM4EMAPTALDH1A1HPGD
SCHEMBL549144 0.66 MAPK1 (0.54) MAPK1LMNAKDM4EMAPTALDH1A1
SCHEMBL21018260 0.65 LMNA (0.42) LMNAKDM4EMAPTALDH1A1HPGD
SCHEMBL1626468 0.65 SPR (0.59) MAPK1LMNAKDM4EMAPTALOX12
SCHEMBL25549318 0.65 KDM4E (0.45) MAPK1LMNAKDM4EMAPTALDH1A1
SCHEMBL19971601 0.65 MAPK1 (0.52) MAPK1KDM4EMAPTHPGDNPSR1
SCHEMBL3304119 0.65 CA12 (0.70) MAPK1KDM4EMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6762188-B1 INHIBITING THYMIDYLATE SYNTHASE; COLON, BREAST OR LUNG CARCINOMA SMITHKLINE BEECHAM CORPORATION 2004-07-13 US disclosed
EP-1199307-B1 Pharmaceutically active benzoquinazoline compounds WELLCOME FOUND (GB) 2004-02-25 EP disclosed
EP-1199307-A1 Pharmaceutically active benzoquinazoline compounds THE WELLCOME FOUNDATION LIMITED (GB) 2002-04-24 EP disclosed
US-6306865-B1 SYNTHASE INHIBITORS AND ANTITUMOR AGENTS GLAXO WELLCOME INC. 2001-10-23 US disclosed
US-6090941-A Pharmaceutically active benzoquinazoline compounds GLAXO WELLCOME INC. (US) 2000-07-18 US disclosed
US-5663337-A ENZYME, ANTITUMOR GLAXO WELLCOME INC. (US) 1997-09-02 US disclosed
US-5661155-A THYMIDYLATE SYNTHASE INHIBITOR; ADMINISTERING TO THE MAMMAL SUFFERING FROM LEUKEMIA OR TUMOR 2-(5-(((1,2-DIHYDRO-3-METHYL-1-OXOBENZO(F)QUINAZOLINE-9-YL) METHYL)AMINO)-1-OXO-2-ISOINDOLINYL)GLUTARIC ACID OR SALTS GLAXO WELLCOME INC. (US) 1997-08-26 US disclosed
US-5405851-A Administering benzoquinazoline thymidylate synthase inhibitors BURROUGHS WELLCOME CO. (US) 1995-04-11 US disclosed
EP-0535034-A1 PHARMACEUTICALLY ACTIVE BENZOQUINAZOLINE COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1993-04-07 EP disclosed
WO-1991019700-A1 PHARMACEUTICALLY ACTIVE BENZOQUINAZOLINE COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1991-12-26 WO disclosed